Taking simvastatin in the morning compared with in the evening: randomised controlled trial
A Wallace, D Chinn, G Rubin - Bmj, 2003 - bmj.com
Statins are widely prescribed for the primary and secondary prevention of coronary artery
disease. They act by inhibiting the enzyme HMG CoA reductase, which controls synthesis of …
disease. They act by inhibiting the enzyme HMG CoA reductase, which controls synthesis of …
Taking simvastatin in the morning compared with in the evening: randomised controlled trial
A Wallace, D Chinn, G Rubin - British Medical Journal, 2003 - go.gale.com
Statins are widely prescribed for the primary and secondary prevention of coronary artery
disease. They act, by inhibiting the enzyme HMG CoA reductase, which controls synthesis of …
disease. They act, by inhibiting the enzyme HMG CoA reductase, which controls synthesis of …
Taking simvastatin in the morning compared with in the evening: randomised controlled trial
A Wallace, D Chinn, G Rubin - BMJ, 2003 - bmj.com
Statins are widely prescribed for the primary and secondary prevention of coronary artery
disease. They act by inhibiting the enzyme HMG CoA reductase, which controls synthesis of …
disease. They act by inhibiting the enzyme HMG CoA reductase, which controls synthesis of …
[引用][C] Taking simvastatin in the morning compared with in the evening: randomised controlled trial
A Wallace, D Chinn, G Rubin - BMJ (Clinical research …, 2003 - pubmed.ncbi.nlm.nih.gov
Taking simvastatin in the morning compared with in the evening: randomised controlled trial
Taking simvastatin in the morning compared with in the evening: randomised controlled trial …
Taking simvastatin in the morning compared with in the evening: randomised controlled trial …
[引用][C] Taking simvastatin in the morning compared with in the evening: randomised controlled trial
A Wallace, GP Rubin, DJ Chinn - British Medical Journal, 2003 - eprints.ncl.ac.uk
Statins are widely prescribed for the primary and secondary prevention of coronary artery
disease. They act by inhibiting the enzyme HMG CoA reductase, which controls synthesis of …
disease. They act by inhibiting the enzyme HMG CoA reductase, which controls synthesis of …
[PDF][PDF] Taking simvastatin in the morning compared with in the evening: randomised controlled trial
A Wallace, D Chinn, G Rubin - BMJ, 2003 - researchgate.net
Statins are widely prescribed for the primary and secondary prevention of coronary artery
disease. They act by inhibiting the enzyme HMG CoA reductase, which controls synthesis of …
disease. They act by inhibiting the enzyme HMG CoA reductase, which controls synthesis of …
Taking simvastatin in the morning compared with in the evening: randomised controlled trial
A Wallace, D Chinn, G Rubin - BMJ: British Medical Journal, 2003 - search.proquest.com
Statins are widely prescribed for the primary and secondary prevention of coronary artery
disease. They act by inhibiting the enzyme HMG CoA reductase, which controls synthesis of …
disease. They act by inhibiting the enzyme HMG CoA reductase, which controls synthesis of …
[引用][C] Taking simvastatin in the morning compared with in the evening: randomised controlled trial
A WALLACE, D CHINN… - BMJ. British medical …, 2003 - pascal-francis.inist.fr
Taking simvastatin in the morning compared with in the evening: randomised controlled trial
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple …
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple …
[HTML][HTML] Taking simvastatin in the morning compared with in the evening: randomised controlled trial
A Wallace, D Chinn, G Rubin - BMJ: British Medical Journal, 2003 - ncbi.nlm.nih.gov
Statins are widely prescribed for the primary and secondary prevention of coronary artery
disease. They act by inhibiting the enzyme HMG CoA reductase, which controls synthesis of …
disease. They act by inhibiting the enzyme HMG CoA reductase, which controls synthesis of …
Taking simvastatin in the morning compared with in the evening: randomised controlled trial.
A Wallace, D Chinn, G Rubin - BMJ (Clinical Research ed.), 2003 - europepmc.org
Statins are widely prescribed for the primary and secondary prevention of coronary artery
disease. They act by inhibiting the enzyme HMG CoA reductase, which controls synthesis of …
disease. They act by inhibiting the enzyme HMG CoA reductase, which controls synthesis of …